乙醛脱氢酶1和雌激素受体在乳腺癌原发灶与复发转移灶之间的表达差异

邵军  潘翠萍  王明伟  吴新红  马彪*

doi:10.3969/j.issn.0529-1356.2013.02.015

解剖学报 ›› 2013, Vol. 44 ›› Issue (2) : 224-228. DOI: 10.3969/j.issn.0529-1356.2013.02.015

肿瘤生物学

乙醛脱氢酶1和雌激素受体在乳腺癌原发灶与复发转移灶之间的表达差异

邵军¹ 潘翠萍¹ 王明伟² 吴新红¹ 马彪^1*

作者信息 +

Discordance of aldehyde dehydrogenase 1 and estrogen Receptor expression between primary and metastatic focuses of breast cancer

SHAO Jun¹PAN Cui-ping¹ WANG Ming-wei² WU Xin-hong¹ MA Biao ^1* 

Author information +

文章历史 +

摘要

目的回顾性分析乙醛脱氢酶1（ALDH1）和雌激素受体（ER）在乳腺癌原发灶和对应复发转移灶之间的表达变化。方法 87例复发转移性乳腺癌，免疫组织化学方法检测复发转移灶及其对应的原发灶中ALDH1和ER的表达差异，利用图像分析软件Image-Pro Plus 6.0 (IPP 6.0)对免疫组织化学结果进行积分吸光度（IA）值测定，并进行统计学分析；结合临床病理特征进行相关性分析。结果 ALDH1在乳腺癌原发灶的阳性率为28.7%（25例），复发转移灶的表达率为43.7%（38例），复发转移灶的阳性率明显高于原发灶，差异有显著性（P <0.05）。ER在原发灶的阳性率为56.3%，在复发转移灶为32.2%，差异有显著性。复发转移灶与对应原发灶IA 值统计分析结果显示，ALDH1的表达量明显升高（P <0.05）,而ER的表达量显著降低（ P <0.01）。ALDH1阳性表达与肿块大小（>2cm）、高组织学分级、淋巴结转移及ER阴性相关。结论乳腺癌复发转移灶中ALDH1的表达率明显高于原发灶，而ER阳性率要显著低于原发灶。

Abstract

Objective To analyze the difference of aldehyde dehydrogenase 1(ALDH1) and estrogen receptor (ER) expression between primary and corresponding metastatic focuses of breast cancer. Methods A total of 87 female patients diagnosed with metastatic breast cancer were included in this study. Immunohistochemistry (IHC) was used to detect the expression of ALDH1 and ER between primary and metastatic sites. Integrated absorbance (IA) of stained sections was measured by Image-Pro Plus 6.0 (IPP 6.0)，and then the statistical analysis was done. Results The incidences of ALDH1 and ER expression among the primary tumor were 28.7%(25 cases) and 56.3% (49 cases), while ascending to 43.7% and declined to 32.2% in corresponding metastatic breast cancer, which were statistically significant respectively (P <0.05 and P <0.01). Statistical analysis results of IA showed that ALDH1 expression in metastatic focuses was obviously higher than that in the corresponding primary tumor, while ER expression was significantly lower. Conclusion The frequencies of ALDH1 positive expression and ER negative expression were more frequently observed in metastatic focuses than in primary breast cancer.

导出引用

邵军潘翠萍王明伟吴新红马彪*. 乙醛脱氢酶1和雌激素受体在乳腺癌原发灶与复发转移灶之间的表达差异[J]. 解剖学报. 2013, 44(2): 224-228 https://doi.org/10.3969/j.issn.0529-1356.2013.02.015

SHAO Jun PAN Cui-ping WANG Ming-wei WU Xin-hong MA Biao* . Discordance of aldehyde dehydrogenase 1 and estrogen Receptor expression between primary and metastatic focuses of breast cancer[J]. Acta Anatomica Sinica. 2013, 44(2): 224-228 https://doi.org/10.3969/j.issn.0529-1356.2013.02.015

参考文献

［1］Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells［J］. Nature, 2001,414 (6859):105-111.

［2］Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells［J］. Proc Natl Acad Sci USA,

2003,100(7):3983-3988.

［3］Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome［J］. Stem Cells, 2007,1(5):555-567.

［4］Ohi Y, Umekita Y, Yoshioka T, et al. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer［J］. Histopathology, 2011,59(4):776-780.

［5］Franco A, Col N, Chlebowski RT. Discordance in estrogen (ER) and progestin receptor (PR) status between primary metastatic breast cancer: a meta-analysis［J］. J Clin Oncol, 2004, 22(14S): 539.

［6］Gong Y, Booser DJ, Sneige N. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma［J］. Cancer, 2005,103(9): 1763-1769.

［7］ Shao J, Pan CP, Ma B. The signal transduction of breast stem cells and breast cancer［J］. Tumor, 2007, 27(9):760-762.(in Chinese)

邵军, 潘翠萍, 马彪. 乳腺干细胞的信号转导与乳腺癌［J］. 肿瘤, 2007，27(9)：760-762.

［8］Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer［J］. Clin Cancer Res, 2010, 16(1): 45-55.

［9］ Nalwoga H, Arnes JB, Wabinga H, et al. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumors in African breast cancer［J］. Br J Cancer, 2010,102(2):369-375.

［10］Deng S, Yang X, Lassus H, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers［J］. PLoS One, 2010,5(4):e10277.

［11］Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker aldehyde

dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression［J］. Cancer Sci, 2009,100(6):1062-1068.

［12］ De Brot M, Rocha RM, Soares FA, et al. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers［J］. Pathology, 2012,44(4):303-312.